What is Resistant Ovary Syndrome?
Resistant ovary syndrome (ROS) is a rare reproductive endocrine disorder characterized by elevated gonadotropin levels (similar to menopause) despite having a normal ovarian reserve, where the ovaries fail to respond adequately to endogenous and exogenous gonadotropin stimulation, resulting in infertility and menstrual disturbances. 1, 2
Clinical Definition and Characteristics
ROS presents with a distinct clinical profile that differentiates it from other causes of ovarian dysfunction:
- Normal sex characteristics and female karyotype (46,XX)
- Normal ovarian reserve (normal antral follicle count, normal anti-Müllerian hormone levels, and normal inhibin B)
- Elevated endogenous gonadotropin levels (FSH and LH in postmenopausal range)
- Low estrogen levels
- Primary or secondary amenorrhea or oligomenorrhea
- Poor or absent response to exogenous gonadotropin stimulation 1, 2, 3
Pathophysiology
The underlying mechanism involves gonadotropin resistance at the ovarian level. The ovaries contain follicles but fail to respond appropriately to FSH and LH stimulation. Recent genetic studies have identified inactivating variants in the FSH receptor (FSHR) gene as one potential cause, inherited in an autosomal recessive pattern 4. However, the pathogenesis remains poorly understood in most cases, and multiple mechanisms may be involved 2.
Distinction from Premature Ovarian Insufficiency (POI)
While ROS shares some features with POI, it is fundamentally different:
- POI is defined as loss of ovarian activity before age 40 with menstrual disturbance, raised gonadotropins, and low estradiol, typically with depleted ovarian reserve 5
- ROS maintains normal ovarian reserve but exhibits gonadotropin resistance 1, 2
- ROS can be considered a specific subtype of POI, but the normal follicular reserve distinguishes it clinically and prognostically 4
Diagnostic Approach
Key diagnostic features to identify:
- Elevated FSH and LH (typically in postmenopausal range)
- Normal or elevated AMH levels (>6 ng/mL in some studies) 6
- Normal antral follicle count on ultrasound
- Normal karyotype (46,XX)
- Absence of response to high-dose exogenous gonadotropins during ovulation induction attempts
- Consider FSHR gene sequencing if available, particularly in familial cases 4
- Rule out autoimmune causes and thyroid dysfunction 3
Clinical Implications
ROS poses significant challenges:
- Infertility is the primary presenting complaint 1, 2
- Unlike POI with depleted reserve, ROS patients theoretically have follicles available but cannot recruit them effectively
- Standard fertility treatments with gonadotropins typically fail 1, 6
- The condition is difficult to diagnose and often confused with other forms of ovarian dysfunction 2
Management Challenges
There is no universally accepted effective treatment protocol for ROS 1, 2. The condition remains one of the most challenging reproductive disorders to manage, with limited evidence-based options and most literature consisting of individual case reports rather than controlled trials.
Note: This is a distinct clinical entity from PCOS with gonadotropin resistance, which involves different pathophysiology and management approaches 7, 8.